PreHevbrio, a 3-Antigen Hepatitis B Vaccine, Gets FDA Approval
PreHevbrio contains the small (S), middle (pre-S2) and large (pre-S1) hepatitis B surface antigens.
Immunization
Pneumococcal 15-Valent Conjugate Vaccine Gets Priority Review for Pediatric Use
The application is supported by data from phase 2 and phase 3 clinical studies that assessed the efficacy and safety of Vaxneuvance in infants, children, and adolescents.
Childhood Vaccination Schedule Not Linked to Type 1 Diabetes
Recommended immunization schedule is not positively associated with the incidence of type 1 diabetes in children
Cervical Cancer Deaths Down Following HPV Vaccine Introduction
Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years
Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved
Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.
Thirty Percent of Hospital-Based Health Care Personnel Unvaccinated
COVID-19 vaccination coverage increased from 36.1 to 60.2 percent from January to April 2021, then slowed, reaching 70.0 percent as of Sept. 15
Longer-Term Data: Pfizer-BioNTech COVID-19 Vaccine Highly Effective in Adolescents
Findings from data collected between November 2020 and September 2021 showed that among 2228 participants, the vaccine was 100% effective.
Vials Found in Lab Contained Vaccine, Not Smallpox Virus: CDC
Federal officials were alerted that the vials were found by a laboratory worker while cleaning out a freezer in the facility
COVID-19 Booster Shots Authorized for All Individuals 18 and Up
Both Companies provided data demonstrating waning neutralizing antibody titers approximately 6 months after completion of the primary series.
White House to Spend Billions to Boost COVID-19 Vaccine Supply
The goal of the plan is to produce at least 1 billion doses a year beginning in the second half of 2022
